Pat Beyer bought CNMD once, on Apr 30, 2024

Patrick “Pat” J. Beyer is a medical technology executive who serves as President and Chief Executive Officer of CONMED Corporation (NYSE: CNMD), having previously held the role of Chief Operating Officer (COO).( He joined CONMED in 2014 as President of International, later expanding his remit to President of International and Global Orthopedics, where he oversaw global orthopedics R&D and U.S. orthopedics commercial operations and led acquisitions including In2Bones and BioRez.( In April 2024 he was promoted to COO, assuming responsibility for CONMED’s global commercial businesses, operations, distribution, regulatory affairs, quality assurance, and customer excellence, and subsequently became CEO effective January 2025.(

Before CONMED, Beyer spent 21 years at Stryker Corporation in progressively senior roles, including leading Stryker Europe, Stryker UK/South Africa/Ireland, and Stryker Medical, and later served as Chief Executive Officer of ICNet International, a privately held infection-control software company.( He has also held board positions at Bioventus and Misonix.( Beyer holds a B.A. in Economics from Kalamazoo College, an M.B.A. in Finance from Western Michigan University, and completed the Advanced Management Program at Harvard Business School, reflecting a blend of commercial, operational, and strategic leadership expertise across the global medtech sector.(

Written by Perplexity from public sources.